Izba Side Effects

Generic name: travoprost ophthalmic

Medically reviewed by Drugs.com. Last updated on Mar 8, 2024.

Note: This document provides detailed information about Izba Side Effects associated with travoprost ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Izba.

Applies to travoprost ophthalmic: ophthalmic solution.

Serious side effects of Izba

Along with its needed effects, travoprost ophthalmic (the active ingredient contained in Izba) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking travoprost ophthalmic:

More common

• eye pain
• itching eye
• redness of the eye
• redness, swelling, or itching of eyelid

Less common

• blurred or decreased vision
• burning, dry, or itching eyes
• eye color changes
• redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid

Other side effects of Izba

Some side effects of travoprost ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• eye discomfort
• feeling of having something in the eye

Less common

• acid or sour stomach (heartburn or indigestion)
• blood in the urine
• chest pain or tightness
• dry eyes
• eye discharge or excessive tearing
• faintness or lightheadedness when getting up from a lying or sitting position
• loss of bladder control
• lower back pain
• muscle pain or stiffness
• pain, swelling, or redness in the joints
• pain or burning while urinating
• pelvic pain
• slow or irregular heartbeat (less than 50 beats per minute)

For healthcare professionals

Applies to travoprost ophthalmic: intraocular implant, ophthalmic solution.

General

The most commonly reported side effect was ocular hyperemia.^[Ref]

Dermatologic

• Uncommon (0.1% to 1%): Skin hyperpigmentation (periocular), skin discoloration, abnormal hair texture, hypertrichosis
• Rare (less than 0.1%): Allergic dermatitis, contact dermatitis, erythema, rash, hair color changes, madarosis
• Frequency not reported: Pruritus, abnormal hair growth^[Ref]

Cardiovascular

• Common (1% to 10%): Angina pectoris, bradycardia, chest pain, hypertension, hypotension
• Uncommon (0.1% to 1%): Palpitations
• Rare (less than 0.1%): Irregular heart rate, decreased heart rate, decreased diastolic blood pressure, increased systolic blood pressure
• Frequency not reported: Tachycardia
• Postmarketing reports: Arrhythmia^[Ref]

Gastrointestinal

• Common (1% to 10%): Dyspepsia, gastrointestinal disorder
• Rare (less than 0.1%): Reactivated peptic ulcer, constipation, dry mouth
• Frequency not reported: Diarrhea, abdominal pain, nausea
• Postmarketing reports: Vomiting^[Ref]

Genitourinary

• Common (1% to 10%): Prostate disorder, urinary incontinence, urinary tract infections
• Frequency not reported: Dysuria, increased prostatic specific antigen^[Ref]

Musculoskeletal

• Common (1% to 10%): Arthritis, back pain
• Uncommon (0.1% to 1%): Shoulder pain
• Rare (less than 0.1%): Musculoskeletal pain
• Frequency not reported: Arthralgia^[Ref]

Nervous system

• Common (1% to 10%): Headache
• Uncommon (0.1% to 1%): Dizziness
• Rare (less than 0.1%): Dysgeusia
• Frequency not reported: Vertigo, tinnitus^[Ref]

Respiratory

• Common (1% to 10%): Bronchitis, cold/flu syndrome, sinusitis
• Uncommon (0.1% to 1%): Dyspnea, asthma, nasal congestion, throat irritation
• Rare (less than 0.1%): Respiratory disorder, oropharyngeal pain, cough, dysphonia
• Frequency not reported: Aggravated asthma
• Postmarketing reports: Epistaxis^[Ref]

Metabolic

• Common (1% to 10%): Hypercholesterolemia^[Ref]

Other

• Common (1% to 10%): Pain
• Uncommon (0.1% to 1%): Asthenia, malaise^[Ref]

Psychiatric

• Common (1% to 10%): Anxiety, depression
• Postmarketing reports: Insomnia^[Ref]

Immunologic

• Rare (less than 0.1%): Herpes simplex, herpetic keratitis^[Ref]

Ocular

• Very common (10% or more): Ocular hyperemia (up to 50%)
• Common (1% to 10%): Decreased visual acuity, eye discomfort, foreign body sensation, eye pain, eyelid pruritus, abnormal vision, blepharitis, blurred vision, cataract, conjunctivitis, corneal staining, dry eye, iris discoloration, keratitis, lid margin crusting, ocular inflammation, photophobia, subconjunctival hemorrhage, tearing
• Uncommon (0.1% to 1%): Corneal erosion, uveitis, iritis, anterior chamber inflammation, punctate keratitis, eye discharge, erythema of eyelid, periorbital edema, ectropion cataract, eyelid margin crusting, growth of eyelashes, eyelash discoloration, asthenopia
• Rare (less than 0.1%): Iridocyclitis, eye inflammation, photopsia, eyelid eczema, conjunctival edema, halo vision, conjunctival follicles, eye hypoesthesia, meibomianitis, anterior chamber pigmentation, mydriasis, eyelash thickening, macular edema, sunken eyes
• Postmarketing reports: Periorbital/lid changes (including deepening of the eyelid sulcus)^[Ref]

Hypersensitivity

• Uncommon (0.1% to 1%): Hypersensitivity, seasonal allergy^[Ref]

Further information

Izba side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer